{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:10:47Z","timestamp":1790341847141,"version":"4.1.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>US cancer diagnoses were substantially lower than expected during the COVID-19 pandemic in 2020. A national study on the extent to which rates recovered in 2021 has not yet been conducted.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine observed vs expected cancer rate trends for January 2020 to December 2021.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional, population-based study of cancer incidence trends used the Surveillance, Epidemiology, and End Results 22 (SEER-22) Registries Database, which covers 47.9% of the US population. Included individuals were those with an invasive cancer diagnosis reported to registries included in SEER-22 between January 1, 2000, and December 31, 2021.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Age, sex, race and ethnicity, urbanicity, and stage at diagnosis.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Expected cancer incidence rates were measured for the COVID-19 pandemic years of 2020 and 2021 from prepandemic trends using ensemble forecasting methods. Relative difference between observed and expected cancer incidence rates and numbers of potentially missed cases were measured.<\/jats:p><\/jats:sec>Results<\/jats:title>The SEER-22 registries reported 1\u202f578\u202f697 cancer cases in 2020 and 2021, including 798\u202f765 among male individuals (50.6%) and 909\u202f654 among persons aged 65 years or older (57.6%). Observed all-sites cancer incidence rates were lower than expected by 9.4% in 2020 (95% prediction interval [PI], 8.5%-10.5%), lower than expected by 2.7% in 2021 (95% PI, 1.4%-3.9%), and lower than expected by 6.0% across both years combined (95% PI, 5.1%-7.1%), resulting in 149\u202f577 potentially undiagnosed cancer cases (95% PI, 126\u202f059-176\u202f970). Of the 4 screening-detected cancers, only female breast cancer showed significant recovery in 2021, exceeding expected rates by 2.5% (95% PI, 0.1%-4.8%), while significant reductions remained for lung cancer (9.1% lower than expected; 95% PI, 6.4%-13.2%) and cervical cancer (4.5% lower than expected; 95% PI, 0.4%-8.0%), particularly for early stage at diagnosis. Rates of all-sites cancer incidence returned to prepandemic trends in 2021 among female individuals, persons aged younger than 65 years, and persons of non-Hispanic Asian and Pacific Islander race and ethnicity.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This population-based cross-sectional study of US cancer incidence trends found that rates of diagnosis improved in 2021 but continued to be lower than expected, adding to the existing deficit of diagnosed cases from 2020. Particular attention should be directed at strategies to immediately increase cancer screenings to make up lost ground.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.32288","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:36:30Z","timestamp":1725636990000},"page":"e2432288","source":"Crossref","is-referenced-by-count":45,"title":["COVID-19 and Rates of Cancer Diagnosis in the US"],"prefix":"10.1001","volume":"7","author":[{"given":"Todd","family":"Burus","sequence":"first","affiliation":[{"name":"Markey Cancer Center, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feitong","family":"Lei","sequence":"additional","affiliation":[{"name":"Markey Cancer Center, University of Kentucky, Lexington"},{"name":"Division of Cancer Biostatistics, College of Medicine, University of Kentucky, Lexington"},{"name":"Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[{"name":"Markey Cancer Center, University of Kentucky, Lexington"},{"name":"Division of Cancer Biostatistics, College of Medicine, University of Kentucky, Lexington"},{"name":"Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Jay","family":"Christian","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Environmental Health, College of Public Health, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela C.","family":"Hull","sequence":"additional","affiliation":[{"name":"Markey Cancer Center, University of Kentucky, Lexington"},{"name":"Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetla","family":"Slavova","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health, University of Kentucky, Lexington"},{"name":"Kentucky Injury Prevention & Research Center, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Tucker","sequence":"additional","affiliation":[{"name":"Markey Cancer Center, University of Kentucky, Lexington"},{"name":"Department of Epidemiology & Environmental Health, College of Public Health, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle A.","family":"Lang Kuhs","sequence":"additional","affiliation":[{"name":"Markey Cancer Center, University of Kentucky, Lexington"},{"name":"Department of Epidemiology & Environmental Health, College of Public Health, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"issue":"4","key":"zoi240970r1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jamaoncol.2023.6969","article-title":"Undiagnosed cancer cases in the US during the first 10 months of the COVID-19 pandemic.","volume":"10","author":"Burus","year":"2024","journal-title":"JAMA Oncol"},{"issue":"5","key":"zoi240970r2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/ijc.v154.5","article-title":"Changes in cancer incidence rates by stage during the COVID-19 pandemic in the US.","volume":"154","author":"Schafer","year":"2024","journal-title":"Int J Cancer"},{"issue":"3","key":"zoi240970r3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/XCS.0000000000000772","article-title":"Delay and disparity in observed vs predicted incidence rate of screenable cancer during the COVID-19 pandemic.","volume":"237","author":"Romatoski","year":"2023","journal-title":"J Am Coll Surg"},{"issue":"1","key":"zoi240970r4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cncr.v130.1","article-title":"Annual Report to the Nation on the Status of Cancer, part 2: early assessment of the COVID-19 pandemic\u2019s impact on cancer diagnosis.","volume":"130","author":"Negoita","year":"2024","journal-title":"Cancer"},{"issue":"8","key":"zoi240970r5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1470-2045(23)00293-0","article-title":"Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.","volume":"24","author":"Han","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"zoi240970r13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-021-01235-8","article-title":"Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions.","volume":"21","author":"Schaffer","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"zoi240970r14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/jamia\/ocac221","article-title":"Performance drift in a mortality prediction algorithm among patients with cancer during the SARS-CoV-2 pandemic.","volume":"30","author":"Parikh","year":"2023","journal-title":"J Am Med Inform Assoc"},{"key":"zoi240970r15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/obes.2005.67.issue-s1","article-title":"Combining density and interval forecasts: a modest proposal.","volume":"67","author":"Wallis","year":"2005","journal-title":"Oxf Bull Econ Stat"},{"key":"zoi240970r16","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ijforecast.2022.11.005","article-title":"Forecast combinations: an over 50-year review.","volume":"39","author":"Wang","year":"2023","journal-title":"Int J Forecast"},{"issue":"13","key":"zoi240970r17","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1245\/s10434-023-14217-5","article-title":"Growing deficit in new cancer diagnoses 2 years into the COVID-19 pandemic: a national multicenter study.","volume":"30","author":"Englum","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"zoi240970r18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.v72.1","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"zoi240970r19","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.22.01704","article-title":"Impact of the COVID-19 pandemic on cancer screening delays.","volume":"41","author":"Zhang","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi240970r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.5058","article-title":"Changes in health care access and preventive health screenings by race and ethnicity.","volume":"5","author":"Alba","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"2","key":"zoi240970r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.55589","article-title":"Breast and lung cancer screening among Medicare enrollees during the COVID-19 pandemic.","volume":"6","author":"Doan","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi240970r22","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.1408","article-title":"Utilization of women\u2019s preventive health services during the COVID-19 pandemic.","volume":"2","author":"Becker","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"3","key":"zoi240970r23","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2020204013","article-title":"Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST Expert Panel Report.","volume":"2","author":"Mazzone","year":"2020","journal-title":"Radiol Imaging Cancer"},{"issue":"36","key":"zoi240970r24","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19\u2013related concerns\u2014United States, June 2020.","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"zoi240970r25","doi-asserted-by":"publisher","first-page":"27285","DOI":"10.1073\/pnas.2012520117","article-title":"Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries.","volume":"117","author":"Galasso","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"zoi240970r26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12913-023-10483-x","article-title":"Factors associated with delay or avoidance of medical care during the COVID-19 pandemic in Armenia: results from a nationwide survey.","volume":"24","author":"Sahakyan","year":"2024","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"zoi240970r27","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1186\/s12913-023-09807-8","article-title":"An association between individual\u2019s risk perceptions and delayed or foregone healthcare services during the COVID-19 pandemic in Korea.","volume":"23","author":"Hwang","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"25","key":"zoi240970r28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.15585\/mmwr.mm7025e2","article-title":"COVID-19 vaccination coverage and intent among adults aged 18-39 years\u2014United States, March\u2013May 2021.","volume":"70","author":"Baack","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi240970r29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/cncr.v118.4","article-title":"Predicting US- and state-level cancer counts for the current calendar year, part I: evaluation of temporal projection methods for mortality.","volume":"118","author":"Chen","year":"2012","journal-title":"Cancer"},{"key":"zoi240970r8","volume-title":"International Classification of Diseases for Oncology: ICD-O","author":"Fritz","year":"2000","edition":"3rd ed"},{"key":"zoi240970r12"},{"key":"zoi240970r6","unstructured":"SEER*Stat database: incidence\u2014SEER research limited-field data, 22 registries, Nov 2023 sub (2000-2021). Surveillance, Epidemiology, and End Results Program, National Cancer Institute. Accessed April 22, 2024. https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2023\/"},{"key":"zoi240970r7","unstructured":"SEER*Stat software. Latest release: version 8.4.3. January 18, 2024. Surveillance, Epidemiology, and End Results Program, National Cancer Institute. Accessed July 30, 2024. https:\/\/seer.cancer.gov\/seerstat\/"},{"key":"zoi240970r9","unstructured":"United States cancer statistics: data visualizations. U.S. Centers for Disease Control and Prevention (CDC). Accessed April 22, 2024. https:\/\/gis.cdc.gov\/Cancer\/USCS\/#\/AtAGlance\/"},{"key":"zoi240970r10","unstructured":"Race and Hispanic ethnicity changes. National Cancer Institute. 2023. Accessed June 11, 2024. https:\/\/seer.cancer.gov\/seerstat\/variables\/seer\/race_ethnicity\/"},{"key":"zoi240970r11","unstructured":"Rural-Urban Continuum Codes. Economic Research Service, US Dept of Agriculture. Accessed January 23, 2024. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-continuum-codes\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2823296\/burus_2024_oi_240970_1724946479.58604.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:36:36Z","timestamp":1725636996000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2823296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.32288","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]}}}